Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Low-glycemic Index Diet and ADHD. (GI-ADHD)

13 november 2026 uppdaterad av: Shimaa Shaker Attia Gafar, Kafrelsheikh University

Effect of Low Glycemic Index Diet in Attention Deficit Hyperactivity Disorder in Children.

This randomized controlled trial will evaluate the effect of a low glycemic index (GI) diet on symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. A total of 128 participants aged 6 to ≤18 years, diagnosed with ADHD according to the Conners Parent Rating Scale-48 (CPRS-48), will be recruited from the pediatric neurology outpatient clinic at Kafrelsheikh University Hospital and randomly assigned in equal numbers (64 per group) to one of two arms. The intervention group will receive a structured low-GI diet (whole grains, legumes, low-GI non-starchy vegetables and fruits, and lean proteins, with refined flour, white rice, and sugary snacks limited) delivered through the Clinical Nutrition Unit, supported by a low-GI pyramid teaching tool, regular dietary counseling, and weekly dietitian review of 3-day food records to monitor adherence. The control group will continue a normal diet. ADHD symptoms will be assessed with the Conners 48 scale at baseline, 1 month, and 6 months. Children with other neurological conditions, autism spectrum disorder, intellectual disability, severe psychiatric conditions, chronic illnesses, diabetes, celiac disease, or food allergies requiring dietary restrictions will be excluded. Written informed consent will be obtained from parents or guardians, and the study has ethics committee approval (REC-KFSIRB200, Kafrelsheikh University).

Suggested additional fields

Primary outcome: Change in Conners 48 score from baseline to 1 and 6 months Study type / design: Interventional; parallel-group randomized controlled trial; prospective Intervention type: Dietary supplement/behavioral (dietary intervention)

Studieöversikt

Status

Har inte rekryterat ännu

Detaljerad beskrivning

Background and rationale

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder of childhood and adolescence, characterized by persistent inattention, hyperactivity, and impulsivity. It affects an estimated 3.4% of children and youth worldwide and places a considerable burden on the individual, family, and society, with consequences that include educational difficulties, strained peer relationships, accidental injuries, and substance misuse. Medication and behavioral therapy are the most effective established treatments, but diet is a modifiable environmental factor that has been explored as a complementary approach. The glycemic index (GI) ranks foods by their effect on blood glucose (low GI: under 55; medium: 55 to 70; high: above 70). It has been proposed that a low-GI diet, by providing a steady supply of glucose to the brain together with nutrients needed for neurotransmitter production, may stabilize blood glucose, improve cognitive performance, and reduce behavioral swings. No previous studies were identified that specifically examine the effect of a low-GI diet on ADHD in children, and clinical research is needed to confirm whether it is effective.

Objective

To explore the effect of a low-GI diet on ADHD symptoms in children and adolescents.

Study design

This is a prospective, interventional, parallel-group randomized controlled trial with two arms. The study will be conducted at the pediatric neurology outpatient clinic of Kafrelsheikh University Hospital, and the dietary intervention will be delivered at the outpatient clinic of the Clinical Nutrition Unit of the same hospital.

Sample size

No prior data were available, so a moderate effect size (Cohen's d = 0.5) was assumed. Using G*Power 3.1.9.7 for a two-tailed independent-samples t-test, with 80% power and a 5% significance level, the required sample size was 128 participants (64 per group).

Participants

128 children and adolescents aged 6 to 18 years with ADHD diagnosed using the Conners Parent Rating Scale-48 (CPRS-48).

Inclusion criteria:

Diagnosis of ADHD according to the Conners 48 scale Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion criteria:

Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Interventions

Group I (intervention, n = 64): Participants will follow a structured low-GI diet based on a Low-GI Pyramid used as a teaching tool. The diet emphasizes whole grains (e.g., oats, barley), legumes (e.g., lentils, beans), non-starchy vegetables and fruits with a GI below 55, and lean proteins, while limiting high-GI foods such as refined flour, white rice, and sugary snacks. Compliance will be monitored through weekly dietitian review of 3-day food records. Regular dietary counseling sessions with parents will reinforce adherence and resolve problems as they arise.

Group II (control, n = 64): Participants will continue their normal diet.

Assessments

All participants will undergo:

Complete history taking (presenting symptoms, onset, duration, impact across settings, family, developmental, medical, and school history) Complete systemic clinical examination (heart, chest, abdomen, and general examination) Comprehensive nutritional assessment, including dietary history, anthropometric measurements (weight, height, BMI, and their Z-scores), and a nutrition-focused physical examination to rule out signs of micronutrient deficiency ADHD symptom assessment using the Conners Parent Rating Scale-48 at baseline, 1 month, and 6 months

Outcome measures

The primary outcome is the change in Conners 48 score from baseline to 1 month and 6 months, compared between the low-GI diet group and the control group. Dietary adherence, based on 3-day food records, is monitored throughout.

Statistical analysis

Data will be analyzed with statistical software using appropriate methods and presented in tables and graphs.

Ethics

The study has been approved by the Scientific Research Ethics Committee, Kafrelsheikh University (REC-KFSIRB200). Written informed consent will be obtained from the parents or guardians of each child before data collection begins.

Studietyp

Interventionell

Inskrivning (Beräknad)

128

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

6 år till 18 år (Barn, Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Diagnosis of ADHD according to the Conners Parent Rating Scale-48 (CPRS-48) Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion Criteria:

  • Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Low glycemic index diet.

Children and adolescents with ADHD (n = 64) follow a structured low-GI diet based on a Low-GI Pyramid teaching tool: whole grains, legumes, low-GI non-starchy vegetables and fruits (GI below 55), and lean proteins, limiting refined flour, white rice, and sugary snacks. Regular dietary counseling sessions and weekly dietitian review of 3-day food records support adherence.

Structured low-GI diet with dietary counseling and weekly review of 3-day food records.

Linked arm: Arm 1

Inget ingripande: Normal diet (control).

Children and adolescents with ADHD (n = 64) continue their usual diet.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in ADHD symptom severity.
Tidsram: Baseline, 1 month, and 6 months.

Change in total score on the Conners Parent Rating Scale-48 (CPRS-48), completed by parents or caregivers. The change from baseline is compared between the low glycemic index diet group and the normal diet group. Higher scores indicate more severe symptoms.

Baseline, 1 month, and 6 months.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

30 november 2026

Primärt slutförande (Beräknad)

30 juni 2027

Avslutad studie (Beräknad)

31 juli 2027

Studieregistreringsdatum

Först inskickad

13 november 2026

Först inskickad som uppfyllde QC-kriterierna

13 november 2026

Första postat (Faktisk)

19 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

19 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

13 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera